Benedict Ifedi, MD | |
23910 Katy Fwy Ste 200, Katy, TX 77494-1477 | |
(281) 500-6120 | |
Not Available |
Full Name | Benedict Ifedi |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 10 Years |
Location | 23910 Katy Fwy Ste 200, Katy, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134531445 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | R5871 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann Katy Hospital | Katy, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
The British Pharmacological Society has announced that its annual meeting, Pharmacology 2014, will showcase the latest research on the NHS care received by children and the elderly in the UK. New findings in these 'Cinderella' areas (so-called because they are often neglected or over-looked) represent just a small sample of the cutting-edge research being presented next week.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.
People who have used cocaine run a great risk of becoming addicted, even after long drug-free periods. Now researchers at Linköping University and their colleagues can point to a specific molecule in the brain as a possible target for treatment to prevent relapses.
› Verified 3 days ago
Entity Name | Memorial Hermann Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
The British Pharmacological Society has announced that its annual meeting, Pharmacology 2014, will showcase the latest research on the NHS care received by children and the elderly in the UK. New findings in these 'Cinderella' areas (so-called because they are often neglected or over-looked) represent just a small sample of the cutting-edge research being presented next week.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.
People who have used cocaine run a great risk of becoming addicted, even after long drug-free periods. Now researchers at Linköping University and their colleagues can point to a specific molecule in the brain as a possible target for treatment to prevent relapses.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Benedict Ifedi, MD 23910 Katy Fwy Ste 200, Katy, TX 77494-1477 Ph: (281) 500-6120 | Benedict Ifedi, MD 23910 Katy Fwy Ste 200, Katy, TX 77494-1477 Ph: (281) 500-6120 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
The British Pharmacological Society has announced that its annual meeting, Pharmacology 2014, will showcase the latest research on the NHS care received by children and the elderly in the UK. New findings in these 'Cinderella' areas (so-called because they are often neglected or over-looked) represent just a small sample of the cutting-edge research being presented next week.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.
People who have used cocaine run a great risk of becoming addicted, even after long drug-free periods. Now researchers at Linköping University and their colleagues can point to a specific molecule in the brain as a possible target for treatment to prevent relapses.
› Verified 3 days ago
Dr. Shamim Ali, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 707 S Fry Rd, Suite 360, Katy, TX 77450 Phone: 281-599-9979 Fax: 281-599-3540 | |
Severino Pimentel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21304 Provincial Blvd, Katy, TX 77450 Phone: 281-206-8280 Fax: 281-206-8285 | |
Quyen Trinh, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21770 Kingsland Blvd, Katy, TX 77450 Phone: 281-646-0740 Fax: 281-646-0743 | |
Dr. Molly Magdalene Nakyonyi-ntwatwa, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
Behrooz Saffari, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23923 Cinco Ranch Blvd, Katy, TX 77494 Phone: 713-486-5300 | |
Eric Samuel Colletti, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 21700 Kingsland Blvd Ste 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-578-4912 | |
Yanielka Cordova Garcia, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 22611 Cremona Village Trl, Katy, TX 77449 Phone: 346-970-9490 |